MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Focused ultrasound subthalamotomy in early Parkinson´s disease: three-year prospective follow-up

E. Natera-Villalba, R. Martínez-Fernández, R. Rodríguez-Rojas, M. Del álamo, JA. Pineda-Pardo, I. Obeso, M. Escribano, T. Jiménez Castellanos, C. Gasca-Salas, M. Matarazzo, JA. Obeso (Madrid, Spain)

Meeting: 2024 International Congress

Abstract Number: 1170

Keywords: Parkinson’s, Stereotactic neurosurgery

Category: Surgical Therapy: Parkinson's Disease

Objective: To assess the safety and efficacy of focused ultrasound subthalamotomy (FUS-STN) for Parkinson´s disease (PD) in patients who received the procedure within the first 5 years since diagnosis (early PD).

Background: FUS-STN improves cardinal motor signs in early PD patients up to one year after the procedure. Whether this benefit persists beyond this timeframe impacting disease progression is unexplored.

Method: Prospective open-label study including asymmetrical PD patients, who underwent unilateral FUS-STN within the first 5 years from diagnosis. Patients were followed up for 3 years after the procedure. The primary outcome was the difference from baseline to 36 months after FUS-STN in the MDS-UPDRS III (off-med) for the treated side. Secondary outcomes were the change in the MDS-UPDRS III (on-med); subscores of rigidity, bradykinesia, tremor; total MDS-UPDRS III; MDS-UPDRS part IV; functional disability (MDS-UPDRS II); quality of life (PDQ39); levodopa equivalent daily dose (LEDD). Adverse events were collected. Non-parametric repeated measures ANOVA was applied for analysis.

Results: Twelve patients were included and all of them were available for the 36-month visit. The mean(±SD) age at baseline was 52.9±7.1 years, with a mean disease duration of 3.1±1.2 years. The MDS-UPDRS III score for the treated side off-med was improved by 66.7% from baseline (from 14.8±2.9 to 5.1±2.7, p<0.001). All motor features were improved. No disabling or new adverse events were reported. The total MDS-UPDRS III off-med score was 48.6% lower at 3 years than before FUS-STN (from 27.4±5.5 to 14.8±8.2, p<0.001). LEDD remained stable 3 years after the procedure (from 643.2±275.2 to 643.4±337.2 mg, n.s.). The MDS-UPDRS IV, II, and PDQ39 scores were equivalent to those at baseline.

Conclusion: FUS-STN provides a sustained motor benefit in early PD patients without safety concerns or management complications. Whether the early treatment improves disease evolution requires a properly designed trial.

References: Martínez Fernández, Raúl et al. “Unilateral focused ultrasound subthalamotomy in early Parkinson’s disease: a pilot study.” Journal of neurology, neurosurgery, and psychiatry vol. 95,3 206-213. 14 Feb. 2024, doi:10.1136/jnnp-2023-331211

To cite this abstract in AMA style:

E. Natera-Villalba, R. Martínez-Fernández, R. Rodríguez-Rojas, M. Del álamo, JA. Pineda-Pardo, I. Obeso, M. Escribano, T. Jiménez Castellanos, C. Gasca-Salas, M. Matarazzo, JA. Obeso. Focused ultrasound subthalamotomy in early Parkinson´s disease: three-year prospective follow-up [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/focused-ultrasound-subthalamotomy-in-early-parkinsons-disease-three-year-prospective-follow-up/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/focused-ultrasound-subthalamotomy-in-early-parkinsons-disease-three-year-prospective-follow-up/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley